A team from the universities of Umeå and Ghent has discovered that neutrophils carefully control zinc levels to weaken and ...

Patients with Duffy null status are more likely to experience misdiagnoses, unnecessary medical tests, and increased health ...

X4 Pharmaceuticals announced the acceptance of two abstracts for presentation at the upcoming European Hematology Association Congress regarding the positive results from their Phase 2 trial of ...

X4 Pharmaceuticals announced that its Phase 3 4WARD trial for chronic neutropenia is now active at around 90% of targeted sites, with expected full enrollment by Q3 or Q4 of 2025 and top-line data ...